Clinical Trials in North Carolina

Showing 10921-10940 of 20,428 trials

Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease

NCT03597139

Evaluate the tolerability, efficacy and safety of VOS versus Restasis® in subjects with mild to moderate Dry Eye Disease (DED).

Dry Eye

Aurinia Pharmaceuticals Inc.100 participantsStarted Aug 2018

Garden Grove, California, United States • Mission Hills, California, United States • Rancho Cordova, California, United States +4 more locations

TERMINATEDPhase 441 miles

Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)

NCT03126760

This study will enroll about 66 participants who experienced a relapse of RRMS that steroids did not help. The doctor will put participants into a treatment group. Each person has an equal chance of being in either one of two groups (like flipping a coin). One group will receive a shot of study medicine (called Acthar Gel) under their skin every day for 14 days. The other group will receive a shot every day for 14 days, too, but there is no medicine in it (called placebo).

Multiple Sclerosis, Relapsing-Remitting

Mallinckrodt ARD LLC35 participantsStarted May 2017

Palo Alto, California, United States • Fort Collins, Colorado, United States • Bradenton, Florida, United States +19 more locations

Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease

Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)

Find Trials by Condition in North Carolina

Pre-medication With Alfentanil vs Placebo During ECT

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery

SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer

Product Performance of a New Silicone Hydrogel Contact Lens

Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)

Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

Viable Allograft Supplemented Disc Regeneration in the Treatment of Patients With Low Back Pain

Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia

Maxigesic IV Phase 3 Bunionectomy Study

A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia

A CD8 Positron Emission Tomography With Computed Tomography (PET/CT) Study Using ⁸⁹Zr Df-IAB22M2C in Patients With Metastatic Melanoma Receiving Bempegaldesleukin (NKTR-214) and Nivolumab

Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

Comparative Effectiveness of Two Treatments for Veterans With PTSD